Replay is a genome writing company reprogramming biology by writing and delivering big DNA.
Replay has raised $55.0M in total funding. The most recent round was Series A. The last funding was announced in July 2022.
Replay's investors include Kohlberg Kravis Roberts & Co., OMX Ventures, Artis Ventures, Lansdowne Partners, Axial VC.
Replay is headquartered in San Diego, United States.
Replay is a genome writing company reprogramming biology by writing and delivering big DNA.
Replay is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Replay — Funding & Investors." VCBacked, July 25, 2022, https://www.vcbacked.co/company/replay-san-diego. Accessed October 21, 2026.
VCBacked. (2022). Replay — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/replay-san-diego
{{cite web |title=Replay — Funding & Investors |url=https://www.vcbacked.co/company/replay-san-diego |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated